The currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19, according to a new paper involving UCL researchers. The study, published in ...

A new program from eMed and the NIH offers free tests and treatments, and you don't even need to leave your home.

A Food and Drug Administration advisory committee voted Tuesday in favor of recommending molnupiravir, a new antiviral pill made by the drug companies Merck and Ridgeback Biotherapeutics, for treating ...

Experts explain what we know about preventing and treating long COVID, at this point. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Add Yahoo as a preferred source to see more of our stories on Google. Doses of the COVID antiviral drug Paxlovid are displayed in New York on Aug. 1, 2022. (Stephanie Nano / Associated Press) The ...

Since COVID-19 first spread rapidly around the world in 2020, we have significantly more options to reduce the symptoms and severity of the virus. COVID-19 symptoms usually begin in the first five ...

Despite a high degree of worry about COVID and experience with severe, long-lasting symptoms, high-risk patients often do not ...

It's good to have a plan in case you test positive for COVID. Know your risk level for severe disease. If you are at high risk, there are treatments available. After a positive test at home, a ...

Dr Jessica Pace is a pharmacy practice academic and practising hospital pharmacist. She is a fellow and the chair of the Society of Hospital Pharmacists Australia (SHPA) NSW branch and member of the ...